Understanding the adoption of new drugs decided by several stakeholders in the South Korean market: a nonparametric event history analysis

Establishing Healthy Pharmaceutical Regulations on Statutory Exclusivity: Lessons from the experience in the European Union, Canada, South Korea, Australia, and the United States

Moderating the Impact of Patent Linkage on Access to Medicines: Lessons from Variations in South Korea, Australia, Canada, and the United States

Compulsory licensing of pharmaceuticals reconsidered: Current situation and its implication on access to medicines

The trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs

Early-Stage Pharmaceutical Market Structures Between Originators and First Generics After Introducing the Patent Linkage System

Measuring the multidimensional reputation of a medicines regulatory agency: development and validation of a public-oriented scale

The impact of increased pharmacy schools on pharmacists' income: is it still an attractive profession?

A Five-Year Analysis of Market Share and Sales Growth for Original Drugs after Patent Expiration in Korea

Perceptions of risk sharing agreements in South Korea from the viewpoints of key stakeholders: a convergent parallel mixed approach